By Brad Pfeffer, MD
Faculty Peer Reviewed
Case: A 75- year-old non-smoking male with a history of type II diabetes, hypertension and hyperlipidemia comes to clinic with several months of …
Category: Cardiology
Clinical Correlations
Appropriateness for Revascularization in Stable Angina
July 22, 2010
Ramin Shayegan Hastings MD, Jonathan Willner MD, and Steven Sedlis MD
Introduction to Cases:
During the past several weeks, we have posted a series of cases addressing the appropriate treatment for patients with stable coronary artery disease. We have …
Appropriateness for Revascularization in Stable Angina
July 1, 2010
Introduction to Cases:
During the upcoming weeks, we will post a series of cases addressing the appropriate treatment for patients with stable coronary artery disease. We will be focus on indications for revascularization in stable …
Appropriateness for Revascularization in Stable Angina
June 9, 2010
Introduction to Cases:
During the upcoming weeks, we will post a series of cases addressing the appropriate treatment for patients with stable coronary artery disease. We will be focus on indications for revascularization …
Appropriateness for Revascularization in Stable Angina
May 19, 2010Introduction to Cases:
During the upcoming weeks, we will post a series of cases addressing the appropriate treatment for patients with stable coronary artery disease. We will be focus on …
Breaking News: The Crestor Controversy
April 1, 2010
Devyani Kothari, MD
Patients are already talking about a New York Times front page article highlighting the risks associated with statin use as a preventive measure for cardiovascular events in relatively “healthy” people. The …
The Evolution of Cardiac Biomarkers: What’s on the Horizon?
March 24, 2010
Rushi Parikh
Faculty peer reviewed
Cardiac biomarkers have historically been a mainstay of the diagnostic criteria of acute coronary syndrome (ACS). Previously utilized cardiac biomarkers include aspartate aminotransferase (AST), …
When Clopidogrel Fails…
March 10, 2010
Marisa Mizus
Faculty peer reviewed
Clopidogrel (Plavix) has been the standard of care for patients with coronary artery disease following percutaneous coronary intervention (PCI) for the past decade. Although …